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Osteoblasts are highly coupled by gap junctions formed by connexin43. Overexpression of connexin45 in osteoblasts
results in decreased chemical and electrical coupling and reduces gene transcription from connexin response elements
(CxREs) in the osteocalcin and collagen I1 promoters. Here, we demonstrate that transcription from the gap junction-
dependent osteocalcin CxRE is regulated by extracellular signal-regulated protein kinase (ERK) and phosphatidylinositol
3-kinase (PI3K) cascades. Overexpression of a constitutively active mitogen-activated protein kinase kinase (MEK), Raf,
or Ras can increase transcription more than twofold of the CxRE, whereas inhibition of MEK or PI3K can decrease
transcription threefold from the osteocalcin CxRE. Importantly, disruption of gap junctional communication by overex-
pression of connexin45 or treatment with pharmacological inhibitors of gap junctions results in reduced Raf, ERK, and
Akt activation. The consequence of attenuated gap junction-dependent signal cascade activation is a decrease in Sp1
phosphorylation by ERK, resulting in decreased Sp1 recruitment to the CxRE and inhibited gene transcription. These data
establish that ERK/PI3K signaling is required for the optimal elaboration of transcription from the osteocalcin CxRE, and
that disruption of gap junctional communication attenuates the ability of cells to respond to an extracellular cue,
presumably by limiting the propagation of second messengers among adjacent cells by connexin43-gap junctions.
INTRODUCTION
Osteoblasts communicate with each other and with osteo-
cytes by gap junctions formed between juxtaposed cells.
Osteoblasts express primarily connexin43 (Cx43), a gap junc-
tion protein that assembles to form channels with perme-
ability that favors negatively charged ions and molecules,
up to 1.2-kDa molecular mass. Genetic studies in mice and
humans have demonstrated the importance of Cx43 for bone
development and turnover. Ablation of the Cx43 gene in
mice results in a delay in endochondral and intramembra-
nous bone formation, due at least in part to a cell autono-
mous osteoblast deficiency (Lecanda et al., 2000). Accord-
ingly, calvarial osteoblasts isolated from Cx43 null mice
demonstrate a delay in expression of many phenotypic
markers of osteogenesis, including the down-regulation of
expression of several genes, including osteocalcin, bone sia-
loprotein, and type I collagen (Lecanda et al., 2000). Recently,
24 separate point mutations in the human Cx43 gene have
been shown to result in the autosomal dominant disorder
oculodentodigital dysplasia (ODDD). (Paznekas et al., 2003;
Kjaer et al., 2004; Richardson et al., 2004) ODDD results in
abnormalities in craniofacial elements, limbs, and dentition.
Despite the accumulating data on the importance of Cx43
in bone biology, the mechanisms by which gap junctions
regulate bone cell function remain uncertain. We hypothe-
size that gap junctions function to equalize or amplify sig-
nals among adjacent cells to coordinate cell activity in re-
sponse to a variety of cues. Consistent with this hypothesis,
it has been reported that disruption of gap junctional com-
munication affects osteoblast gene transcription. Disruption
of gap junctional coupling in osteoblasts results in down-
regulation of markers of osteogenesis, including osteocalcin
and bone sialoprotein (Lecanda et al., 1998; Li et al., 1999;
Schiller et al., 2001a,d; Stains et al., 2003). ROS17/2.8 rat
osteosarcoma cells are highly coupled by gap junctions
formed exclusively by Cx43 (Steinberg et al., 1994). It has
been demonstrated that overexpression of connexin45
(Cx45), which forms gap junctions with smaller size and
opposite charge permeability than Cx43, in these cells results
in a drastic decrease in chemical and electrical coupling of
the resulting heteromeric gap junctions, indicating that in a
mixed Cx43/Cx45 environment the biophysical properties
of Cx45 prevail. Thus, Cx45 acts as a partial dominant neg-
ative connexin for Cx43 function (Koval et al., 1995; Li et al.,
1999; Martinez et al., 2002). Using this model of Cx45 over-
expression to inhibit the gap junctional communication pro-
vided by Cx43, we and others have observed close similar-
ities with osteoblasts derived from Cx43 null mice, including
down-regulation of osteocalcin and bone sialoprotein tran-
scription (Lecanda et al., 1998; Li et al., 1999; Stains et al.,
2003).
Recently, we have exploited the partial dominant negative
action of Cx45 on Cx43 function to elucidate the molecular
mechanisms by which gap junctional communication mod-
Article published online ahead of print. Mol. Biol. Cell 10.1091/
mbc.E04–04–0339. Article and publication date are available at
www.molbiolcell.org/cgi/doi/10.1091/mbc.E04–04–0339.
* Present address: Department of Orthopaedics, University of Mary-
land School of Medicine, Baltimore, MD 21201.
† Corresponding author. E-mail address: rcivitel@im.wustl.edu.
Abbreviations used: CMV, cytomegalovirus; Cx43, connexin43;
Cx45, connexin45; CRE, cAMP response element-binding protein
response element; CxRE, connexin response element; ERK, extracel-
lular signal-regulated kinase; FBS, fetal bovine serum; MAPK, mi-
togen-activated protein kinase; OC, osteocalcin; ODDD, oculoden-
todigital dysplasia; PI3K, phosphatidylinositol 3-kinase; RSV, Rous
sarcoma virus; SRE, serum response element.
64 © 2004 by The American Society for Cell Biology
ulates gene transcription in osteoblasts (Stains et al., 2003).
We identified a minimal element (70 to 57 relative to
transcription start) in the proximal promoter of the osteocal-
cin (OC) gene that is sensitive to gap junctional communi-
cation. We termed this unique transcriptional element a
connexin response element (CxRE). We identified the com-
plex binding the OC CxRE as containing the ubiquitous
transcription factors Sp1 and Sp3 and demonstrated that Sp1
can activate transcription from this element, whereas Sp3
represses transcription. Finally, we demonstrated that gap
junctional communication regulates transcription by alter-
ing the recruitment of Sp1/Sp3 to the promoter. Under well
coupled conditions, the transactivator Sp1 is phosphorylated
and preferentially recruited to the CxRE. Disruption of
Cx43-gap junctions by overexpression of Cx45 leads to the
preferential recruitment of the repressor Sp3. We hypothe-
size that second messengers passing through Cx43-gap junc-
tions activate signal transduction pathways leading to the
recruitment of Sp1.
In the present study, we undertake a molecular approach
to define the pathways that link the gap junction channel at
the plasma membrane to the transcription factors binding
the CxRE in the nucleus. By defining the molecular details of
how Cx43-gap junctions modulate cell function, we hope to
gain insights into their biological role.
MATERIALS AND METHODS
Cell Culture and Reagents
ROS17/2.8 cells were cultured in -minimal essential medium  10% fetal
bovine serum (FBS), as reported previously (Stains et al., 2003). Growth
arrested cells were obtained by deprivation of serum for 24 h. Pretreatment
with inhibitors were performed for 20 min before stimulation with 10% FBS.
Routine molecular biology reagents and chemicals were from Promega (Mad-
ison, WI) and Sigma-Aldrich (St. Louis, MO), respectively. Antibodies against
signal pathway components were from Cell Signaling Technology (Beverly,
MA). Anti-GAPDH antibodies were from Chemicon International (Temecula,
CA). Anti-Sp1 antibodies were from Santa Cruz Biotechnology (Santa Cruz,
CA). Anti-phospho-Sp1 (Thr739) antibodies were a kind gift from Gilles Pages
(Centre Antoine Lacassagne, Nice, France). The constitutively active pFC-
MEK1 was from Stratagene (La Jolla, CA). The constitutively active RAF
(pCMV RafCAAX) and RAS (pCMV RasV12) and the signal pathway-specific
reporters (pAP1-LUC, pCRE-Luc and pSRE-Luc) were from BD Biosciences
Clontech (Palo Alto, CA).
Plasmid Constructs
The OC CxRE-RSVLUC luciferase reporter construct contains a single copy of
the osteocalcin CxRE cloned upstream of a Rous sarcoma virus minimal
promoter and has been described previously (Stains et al., 2003). The RSV
minimal promoter has been described by others (Boudreaux and Towler,
1996). The OC CxRE spans the 70 to 57 region (relative to the transcrip-
tional start site) of the rat osteocalcin proximal promoter. The pcDNA-cCx45
plasmid was generated by subcloning the chicken Cx45 (cCx45) coding se-
quence from the pSFFV-cCx45 (provided by Dr. Thomas Steinberg, Washing-
ton University, St. Louis, MO) into the EcoRI site of pcDNA3.
Transfections and Luciferase Reporter Assays
Transfections were performed as described previously (Stains et al., 2003,
2004). Briefly, ROS17/2.8 cells were seeded at high density (2  105 cells/
well) in 24-well plates. Sixteen hours later, the cells were transfected with the
appropriate plasmid by using LipofectAMINE reagent according to manu-
facturer’s directions. Reporter plasmid (0.5 g/well) and pcDNA-cCx45 ex-
pression plasmid (0.25 g/well) were used in each transfection. Total DNA
content was kept constant in all experiments by addition of pcDNA. After
48 h, the cells were rinsed in phosphate-buffered saline (PBS) and lysed in 1
passive lysis buffer. Luciferase activity was monitored using an Optocomp
luminometer. Transfection efficiency was monitored by cotransfection with a
-galactosidase reporter. All experiments were performed in triplicate and
repeated three to five times.
Western Blotting and Immunoprecipitations
Whole cell extracts from ROS17/2.8 cells were prepared using modified
radioimmunoprecipitation assay buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 10
mM sodium pyrophosphate, 10 mM sodium fluoride, 10 mM -glycerophos-
phate, 1 mM EGTA, 1 mM EDTA, 2 mM sodium vanadate; 1% NP-40, 0.5%
sodium deoxycholate, 0.1% SDS plus protease inhibitors) containing protease
and phosphatase inhibitors. Insoluble material was pelleted and the super-
natants were electrophoresed on 10% SDS-PAGE gels and transferred to
polyvinylidene difluoride membranes. Membranes were blocked in 5% non-
fat dry milk, probed with the indicated primary antibodies, and detected with
the appropriate horseradish peroxidase-conjugated antibodies (1:5000) and
enhanced chemiluminescence detection reagents. Densitometry was per-
formed on immunoblots by using a UVP EpiChem3 gel documentation sys-
tem and Labworks 4.0 software. Immunoprecipitations were performed using
500 g of whole cell extract and 3 g of anti-phospho-threonine antibodies.
Immunoprecipitated material was collected using protein A/G plus. Washed
immunoprecipitated material was eluted in SDS sample buffer, immuno-
blotted, and probed with anti-Sp1 antibodies.
Formaldehyde Cross-linking and Chromatin
Immunoprecipitation (ChIP)
Formaldehyde ChIP assay was performed as described previously (Stains et
al., 2003). Briefly, ROS17/2.8 were transiently transfected with pcDNA or
pcDNA-cCx45 by using Lipofectamine. The cells were then treated with
vehicle (0.1% dimethyl sulfoxide [DMSO]) or 10 M U0126 overnight. The
following day, the cells were rinsed twice in PBS, and cross-linked in 1%
formaldehyde at room temperature for 10 min. Cells were collected, lysed,
and the fixed chromatin was sonicated 10 times for 10 s each. Sheared
genomic DNA was electrophoresed on an agarose gel to ensure complete
shearing of the DNA. The cross-linked chromatin was diluted with immuno-
precipitation (IP) buffer (20 mM Tris, pH 8, 150 mM NaCl, 2 mM EDTA, 1%
Triton X-100), precleared with protein A/G Plus, and then immunoprecipi-
tated with 3 g of rabbit anti-Sp1 antibodies. The immunoprecipitated mate-
rial was then washed and eluted as described by Shang et al. (2002). Protein
cross-links were reversed by heating overnight at 65°C. DNA was purified
using QIAquick polymerase chain reaction (PCR) purification kit. For PCR, 1
l from a 50-l extraction was used per reaction. Titration of PCR conditions
was performed to ensure experiments were performed in a linear range of
amplification. PCR primers used OC Promoter-F, CCAATTAGTCCTGGCAG-
CAT; OC Promoter-R, TTGCTGTGTGGGACTTGTCT; COL1A1 Promoter-F,
TGGACTCCTTTCCCTTCCTT; and COL1A1 Promoter-R, GAACCCTGC-
CTCTTGGAGA.
RESULTS
Previously, we reported that overexpression of exogenous
Cx45 in an endogenous Cx43 background results in dimin-
ished gap junctional communication leading to repressed
gene transcription from CxREs (Lecanda et al., 1998; Stains et
al., 2003). To prove that this effect was due to loss of Cx43
function and not gain of Cx45 function, we assessed the
ability of pharmacological inhibitors of gap junctions to
inhibit CxRE-driven gene transcription. Treatment of cells
with the gap junction inhibitor oleamide reduced transcrip-
tion of the OC CxRE to levels similar to that observed in
Cx45 overexpression (Figure 1A). This effect was dose de-
pendent, with the best levels of inhibition observed at 100
M. This concentration of oleamide is consistent with the
levels required to disrupt gap junctional coupling (Schiller et
al., 2001c; Subauste et al., 2001; Krutovskikh et al., 2002;
Ransjo et al., 2003). Similarly, the gap junction inhibitor
18-glycyrrehetinic acid exhibited dose-dependent inhibi-
tion of CxRE-mediated gene transcription (Figure 1B). In
contrast, the inactive analog glycyrrhizic acid did not affect
transcription. These data support the notion that the effect of
Cx45 overexpression on gene transcription is caused by loss
of Cx43 function.
Extracellular Signal-regulated Protein Kinase (ERK)
Controls Transcription from the OC CxRE
We hypothesized that disruption of Cx43-gap junctions lim-
its the capacity to propagate signal molecules among cou-
pled cells, resulting in attenuated activation of signal trans-
duction cascades. We directed our focus on the ERK
mitogen-activated protein kinase (MAPK) cascade, which
has been shown to regulate phosphorylation and transcrip-
tional activity of Sp1 (Merchant et al., 1999; Milanini-
Mongiat et al., 2002). Because we had demonstrated previ-
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ously that the alteration in gene transcription caused by
perturbation of gap junctional communication is caused by
posttranslational modification of Sp1, we hypothesized that
ERK signaling is a likely candidate for modulating Sp1
recruitment to CxREs (Stains et al., 2003).
To assess the influence of ERK signaling on the OC CxRE,
we used a promoter-luciferase reporter system containing a
single copy of the OC CxRE placed upstream of an RSV
minimal promoter (OC CxRE-RSVLUC). ROS17/2.8 cells
were transiently cotransfected with the OC CxRE-RSVLUC
reporter and pcDNA-cCx45 or pcDNA. As expected from
our previous data, overexpression of Cx45 reduced tran-
scription from the OC CxRE 2.5-fold, and treatment with 100
M oleamide reduced transcription 4.8-fold (Figure 2).
Whereas treatment with the p38 MAPK inhibitor SB203580
had no effect on transcription, cell exposure to 10 M U0126,
an inhibitor of mitogen-activated protein kinase kinase
(MEK)1/2, which is upstream of ERK, reduced transcription
to levels similar to that obtained from disruption of gap
junctions (Figure 2). The role of ERK cascade signaling in
regulating CxRE transcription was confirmed by overex-
pression of constitutively active MEK (pFC-MEK1), Raf (Raf-
CAAX), and Ras (Ras V12) constructs in luciferase reporter
assays. All three constructs supported at least a twofold
increase in CxRE transcription, demonstrating that the
Ras  Raf  MEK  ERK cascade can modulate transcrip-
tion from the OC CxRE.
ERK Signaling Is Regulated by Gap Junctional
Communication
We next examined whether ERK activity is affected by dis-
ruption of Cx43-mediated gap junctional communication.
First, we assessed the “basal” activation of ERK in ROS17/
2.8 cells maintained in 10% FBS. Cells were transiently trans-
fected with either pcDNA-cCx45 or pcDNA, or treated with
100 M oleamide. As shown in Figure 3A, Western blotting
with anti-phospho-ERK antibodies revealed a nearly two-
fold reduction in active ERK when gap junctions communi-
cations was perturbed either by overexpression of a domi-
nant connexin (i.e., Cx45) or by treatment with the gap
junction inhibitor oleamide. Total ERK in the cell extract was
unaffected. Likewise, the levels of activated Raf were dimin-
ished twofold when gap junctional communication was at-
Figure 1. Disruption of gap junctional communication leads to a
decrease in transcription from the OC CxRE. ROS17/2.8 cells were
transfected with the OC CxRE-RSVLUC luciferase reporter and
treated for 16 h with the gap junction inhibitors. (A) Treatment of
the cells with the gap junction inhibitor oleamide decreased tran-
scription from the OC CxRE, as determined by luciferase activity.
The most effective dose of oleamide was 100 M. DMSO was used
as a vehicle control (0.1%). (B) Treatment of the cells with the gap
junction inhibitor 18-glycyrrhetinic acid decreased transcription
from the OC CxRE in a dose-dependent manner, as determined by
luciferase activity. The inactive analog glycyrrhizic acid did not
affect CxRE-mediated transcription. Data are presented as mean 
SD from a representative experiment performed in triplicate. Aster-
isk indicates significant difference (p 0.05) compared with control.
Figure 2. ERK activity modulates tran-
scription from the OC CxRE. ROS17/2.8
cells were transiently cotransfected with
pcDNA-cCx45 or pcDNA and OC CxRE-
RSVLUC reporter plasmid. Cells were
treated with 100 M oleamide, 10 M
SB203580, 10 M U0126, or vehicle (0.1%
DMSO) for 16 h. At 48 h posttransfection,
the cells were assayed for luciferase activity.
In some instances, cells were cotransfected
with constitutively active (CA) MEK, Raf,
and Ras. Transcription from the OC CxRE
reporter was reduced two- to threefold by
overexpression of cCx45, treatment with 100
M oleamide (gap junction inhibitor) and
with 10 M U0126 (MEK inhibitor), but not
by 10 M SB203580 (p38 inhibitor). In con-
trast, transcription was increased nearly
two- to threefold by expression of the CA
MEK, CA Raf, and CA Ras. Data are pre-
sented as mean  SD from a representative
experiment performed in triplicate. Asterisk
indicates significant difference (p  0.05)
compared with pcDNA control.
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tenuated. In contrast, the activation of p38 MAPK was
slightly increased under the same conditions, as assessed
using an anti-phospho-p38 MAPK antibody.
According to our hypothesis, we anticipated that Cx43-
gap junctions potentiate signaling among cells in response to
an extracellular cue by propagating second messengers to
adjacent cells. Thus, cells with disrupted gap junctional com-
munication would have an attenuated response to an extra-
cellular cue. To test this hypothesis, we analyzed the ability
of cells to activate ERK after stimulation with serum in well
coupled cells and in cells with diminished gap junctional
communication. Growth-arrested cells were either trans-
fected with pcDNA-cCx45 or treated with the gap junction
inhibitors oleamide (100 M) or 18-glycyrrhetinic acid (5
M). Cells transfected with pcDNA or treated with DMSO
(0.1%) or the inactive analog glycyrrhizic acid (5 M) served
as the respective controls. Consistent with the results on
“basal” ERK activation, immunoblotting with anti-phospho
ERK antibodies revealed that well coupled cells had a two-
to threefold higher activation of ERK in response to 10% FBS
at 5, 10, or 15 min after stimulation (Figure 3B). Importantly,
the activation of ERK under the well coupled conditions
used in the control experiments reveal the total activation of
ERK by both extracellular ligand-receptor–mediated activa-
tion and gap junctional propagation of the signal. The ERK
activation observed under conditions of disrupted gap junc-
tional communication reflects only the extracellular ligand-
receptor–mediated activation. By inference, these data dem-
Figure 3. ERK but not p38 MAPK signaling is attenuated by disruption of gap junctional communication. (A) ROS17/2.8 cells were
transiently transfected with pcDNA-cCx45 or pcDNA. Cells were treated with 100 M oleamide for 16 h, where indicated. Forty-eight hours
posttransfection, whole cell extracts were prepared, electrophoresed, and immunoblotted by using phospho-ERK, total ERK, phospho-Raf,
total Raf, phospho-p38 MAPK, and GAPDH antibodies. Overexpression of cCx45 or treatment with oleamide markedly reduced phosphor-
ylated, but not total ERK and Raf abundance compared with mock-transfected cells. The abundance of phosphorylated p38 MAPK was
slightly increased by Cx45 or oleamide. (B) ROS17/2.8 cells were transfected with pcDNA-cCx45 or pcDNA. At 24 h posttransfection, the cells
were serum deprived overnight. The following day, the cells were stimulated with 10% FBS for 5, 10, or 20 min, after pretreatment for 20 min
with either 100 M oleamide, 0.1% DMSO, 5 M 18-glycyrrhetinic acid (18-GA), or 5 M glycyrrhizic acid (GA). The cells were
subsequently lysed, electrophoresed, and immunoblotted using anti-phospho-ERK antibodies. Total ERK was used to normalize load
amounts. The activation of ERK was markedly reduced in gap junction communication disrupted cells after 5, 10, and 20 min of serum
stimulation. The ratio of phosphorylated to total protein is shown beneath each blot.
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onstrate that gap junctional communication provided by
Cx43 accounts for 50–60% of the total cellular response to an
extracellular cue, because ERK activation in response to
serum stimulation is attenuated more than twofold by dis-
ruption of Cx43-gap junctions.
To validate that ERK activity is decreased as a conse-
quence of Cx45 overexpression, a series of signal pathway-
specific reporter constructs were used in cCx45 cotransfec-
tion experiments, including a serum response element
luciferase reporter (SRE-LUC), constituting an Elk1/Srf cog-
nate, and from an AP1-binding reporter (AP1-LUC), con-
taining a Fos/Jun cognate, which are responsive to changes
in ERK activity, as well as a p38 MAPK/c-Jun NH2-terminal
kinase-responsive cAMP-response element reporter (CRE-
LUC). Consistent with the immunoblotting data, transcrip-
tion from both the ERK-sensitive SRE- and AP1-LUC was
markedly decreased in Cx45 overexpressing cells. In con-
trast, transcription from the p38-responsive CRE-LUC was
weakly increased by Cx45 overexpression (Figure 4). Thus,
disruption of Cx43-gap junctions by cCx45 expression seems
to specifically affect the ERK signaling pathway, rather than
Sp1 activity directly, because transcription from an AP1 and
SREs, which do not involve Sp1, also were down-regulated
by cCx45 expression.
Activation of the ERK Cascade Rescues the Gap
Junctional Regulation of CxRE-mediated Transcription
Having shown a role for ERK signaling in Cx43-gap junc-
tion-regulated gene transcription, we next determined
whether activation of the ERK signaling cascade could res-
cue the transcriptional defect observed when Cx43 gap junc-
tions are disrupted. Thus, we used constitutively active up-
stream transducers of the ERK cascade in cotransfection
experiments with pcDNA-cCx45 and the OC CxRE-RSVLUC
reporter. Overexpression of constitutively active MEK1, Raf,
and Ras all rescue the transcriptional repression caused by
overexpression of cCx45 on the OC CxRE (Figure 5). These
data directly implicate the Ras  Raf  MEK  ERK signal-
ing cascade in connexin modulation of transcriptional activity.
However, cell exposure to the PI3K inhibitor LY294002
also decreased OC CxRE transcriptional activity by 50%
(Figure 6A). Because PI3K can act either upstream or down-
stream of Ras and can activate other signaling pathways,
such as Akt, we then tested whether overexpression of
cCx45 affected PI3K  Akt signaling. Intriguingly, overex-
pression of cCx45 also attenuated Akt phosphorylation
without affecting total Akt present in the cells (Figure 6B),
suggesting that overexpression of Cx45 in a Cx43 back-
ground regulates PI3K activity, with consequent attenuation
of activity of downstream effectors, Akt and the Ras  ERK
pathways.
ERK Signaling Is Required for the Phosphorylation and
Recruitment of Sp1 to the CxRE
It has been reported that Sp1 is a target of phosphorylation
by ERK signaling on threonine 453 and 739 (Milanini-
Mongiat et al., 2002) and that phosphorylation of Sp1 by ERK
leads to increased DNA binding (Merchant et al., 1999). We
have previously demonstrated that Sp1 is phosphorylated in
ROS 17/2.8 cells, but when Cx43-gap junctions are dis-
rupted by Cx45 overexpression the level of threonine phos-
phorylation is dramatically reduced (Stains et al., 2003). To
assess whether ERK activity is responsible for the decrease
in Sp1 phosphorylation induced by Cx45 overexpression, we
performed immunoprecipitations by using anti-phospho-
threonine antibodies in cells transfected with either pcDNA-
cCx45 or empty vector, and treated with 10 M U0126 or
vehicle. The immunoprecipitated material was then immu-
noblotted with anti-Sp1 antibodies. As shown in Figure 7A,
phosphorylation of Sp1 was reduced by Cx45 overexpres-
sion and treatment of the cells with 10 M U0126. These
results were validated using an anti-phospho Sp1 (Thr739)
antibody (generous gift of Dr. Gilles Pages). The threonine
phosphorylation of Sp1 was markedly reduced in 10 M
Figure 4. Transcription from ERK but not p38 signal pathway-
specific reporters is repressed by Cx45 overexpression. ROS 17/2.8
cells were cotransfected with the signal pathway-specific reporters
SRE-LUC, AP1-LUC, or CRE-LUC along with either pcDNA or
cCx45. At 48 h posttransfection, the cells were assayed for luciferase
activity. Activity of the SRE- and AP1-LUC reporters, which are
regulated by the ERK signaling cascade, was significantly reduced
when cCx45 was expressed compared with pcDNA-transfected
cells. In contrast, the p38 MAPK regulated CRE-LUC reporter was
unaffected by cCx45 overexpression. Data are presented as mean 
SD from a representative experiment performed in triplicate. Aster-
isk indicates significant difference (p 0.05) compared with pcDNA
control.
Figure 5. Overexpression of constitutively active (CA) MEK, Raf,
or Ras “rescues” the transcriptional deficiency caused by Cx45
overexpression. (A) ROS 17/2.8 cells were cotransfected with
pcDNA-cCx45 or pcDNA, and OC CxRE-RSVLUC in the presence
or absence of CA MEK, CA Raf, or CA Ras. The transcriptional
repression from the OC CxRE caused by Cx45 overexpression was
“rescued” by all three constitutively active mutants. Data are pre-
sented as mean  SD from a representative experiment performed
in triplicate. Asterisk indicates significant difference (p  0.05) com-
pared with pcDNA control. Double asterisks indicate significant
difference (p  0.05) compared with pcDNA-cCx45 control.
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U0126-treated or Cx45-overexpressing cells compared with
those transfected with pcDNA, whereas the abundance of
total Sp1 was unaffected (Figure 7B).
The biological relevance of Sp1 phosphorylation by ERK
was determined by chromatin immunoprecipitations. We
examined whether interference with ERK activity alters Sp1
occupancy of both the OC CxRE and the collagen I 1
CxREs. As previously shown, Sp1 was detected to bind both
the OC and collagen I 1 CxREs in pcDNA-transfected cells,
and the abundance of Sp1 on the CxRE was markedly re-
duced when the cells were transfected with pcDNA-cCx45
(Figure 7C). Importantly, cell exposure to 10 M U0126
greatly reduces the recruitment of Sp1 to both promoters,
confirming the notion that ERK signaling increases recruit-
ment of Sp1 to CxREs. Thus, signaling via ERK, which is
modulated by gap junctional communication, is required for
threonine phosphorylation of Sp1. As a result of this post-
translational modification, recruitment of Sp1 to the CxRE is
enhanced and gene transcription is up-regulated, establish-
ing the ERK cascade as a molecular link between Cx43 at the
plasma membrane and CxREs in the nucleus.
DISCUSSION
The cell-to-cell diffusion of signal molecules through gap
junctions within a cell network allows a coordinated action
of cells in a population. Accordingly, disruption of such
coordinated activity may result in cell dysfunction. Indeed,
connexin mutations have been associated with a number of
congenital disorders of various tissues, for example Charcot-
Marie-Tooth disease (Bergoffen et al., 1993), nonsyndromic
deafness (Kelsell et al., 1997), oculodentodigital dysplasia
(Paznekas et al., 2003; Richardson et al., 2004), as well as
neoplasia (Pitts et al., 1988; Cesen-Cummings et al., 1998).
There is now ample evidence that one mechanism by which
gap junctions affect cellular function is via regulating gene
transcription (Philippe et al., 1994; Vozzi et al., 1995; Nichol-
son et al., 2001; Flachon et al., 2002; Fritz et al., 2002; Huang
et al., 2002; Kojima et al., 2002). In previous work, we have
demonstrated such a role for Cx43 in bone. Either dominant
(Cx45 overexpression) or recessive (gene deletion) disrup-
tion of Cx43 function results in an altered expression of
osteoblastic genes (Lecanda et al., 1998, 2000; Stains et al.,
2003). We have attributed these transcriptional changes to
connexin modulation of recruitment of transcription factors
Sp1/Sp3 to CxREs in at least two osteoblast promoters
(Stains et al., 2003).
In this report, we demonstrate that the type of gap junc-
tional communication provided by Cx43 is essential for op-
timal activation of signal transduction through ERK. We
hypothesize that the cellular response to an extracellular cue
is twofold. There is a “primary” response of the cells to an
extracellular stimulus (e.g., growth factors, such as serum
used in this study) that is mediated by the classical extra-
cellular ligand-receptor activation. This leads to activation of
signal transduction and generation of second messengers.
When gap junctions are present, propagation of these sec-
ond messengers to adjacent cells by gap junctions leads to a
“secondary” response. This gap junction-dependent second-
ary response is mediated at least in part by activation of the
ERK signal transduction cascade. Importantly, our data
demonstrate that the gap junction component of cellular
response to an extracellular cue accounts for as much as 50%
of the total response of a population of cells. Such a model
for the role of gap junctions, particularly those composed of
Cx43, in coordinating homogeneous signaling among cells
in a local population has been recently reported (Lin et al.,
2004). Furthermore, the ability of Cx43 gap junctions to
propagate second messengers has been well documented
(Boitano et al., 1992; Goldberg et al., 1998; Kam et al., 1998;
Niessen et al., 2000). The advantages of using gap junctions
to propagate a signal are twofold. First, gap junctions permit
a uniform response to an extracellular signal in cells that
may have heterogeneous expression level of receptors or
limited access to the extracellular ligand (e.g., osteocytes).
Second, gap junctions permit a rapid and specific transfer of
signals among adjacent cells, coordinating the function of
local populations of cells, and allowing only coupled cells to
respond.
In addition to the ERK pathway, we have evidence that
the PI3K and Akt pathway may be likewise affected by
disruption of Cx43-gap junctions. In some contexts, PI3K has
been shown to act upstream of ERK (Karnitz et al., 1995;
Parrizas et al., 1997). In other tissues, the PI3K pathway acts
independent of ERK. Therefore, it is not clear whether the
effect of Cx45 overexpression on both Akt and ERK repre-
sents divergence of signaling from PI3K activation, or cross
talk among the two arms of cellular signaling by second
messengers traversing the gap junction.
Figure 6. The PI3K/Akt pathways also regulated transcription
from the OC CxRE and are regulated by gap junctional communi-
cation. (A) ROS 17/2.8 cells were cotransfected with pcDNA-cCx45
or pcDNA, and OC CxRE-RSVLUC. Twenty-four hours posttrans-
fection the cultures were treated with 10 M LY294002, an inhibitor
of PI3K, or vehicle (0.1% DMSO). At 48 h posttransfection, the cells
were harvested and assayed for luciferase activity. Treatment with
the PI3K inhibitor decreased transcription from the OC CxRE two-
fold. Data are presented as mean of triplicate samples  SD from a
representative experiment. Asterisk indicates significant difference
(p  0.05) compared with pcDNA control. (B) ROS17/2.8 cells were
transiently transfected with pcDNA-cCx45 or pcDNA, or treated
with 0.1% DMSO or 100 M oleamide. Whole cell extracts were
prepared, electrophoresed, and immunoblotted using phospho-Akt
antibodies. The blot was then stripped and reprobed using a total-
Akt antibody. Disruption of Cx43-gap junctional communication
reduced the abundance of the activated phospho-Akt.
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We propose a model in which second messengers, acti-
vated by a primary cell response to an extracellular cue, are
propagated by Cx43-gap junctions. We term this the gap
junction-dependent secondary response. On traversing the
gap junctional pore, the second messenger activates Ras 
Raf  MEK  ERK and PI3K  Akt signaling. The activated
ERK is subsequently translocated to the nucleus where it
phosphorylates Sp1 leading to its preferential recruitment to
the CxRE, leading to robust gene transcription and a poten-
tiation of the primary response. When the permeability of
gap junctions is decreased by the formation of Cx43/Cx45
heteromeric channels or pharmacological inhibition, activa-
tion of the Ras  ERK pathway is markedly decreased. This
results in hypophosphorylation of Sp1 and a concomitant
failure to recruit Sp1 to the promoter and diminished gene
transcription (Figure 8). Whether PI3K/AKT signaling acts
in a parallel or linear manner with respect to ERK signaling
remains to be determined.
Figure 7. Disruption of the ERK signaling
cascade results in decreased threonine phos-
phorylation of Sp1 and recruitment to the
CxRE. (A) ROS17/2.8 cells were transiently
transfected with pcDNA-cCx45 or pcDNA.
After 24 h, cells were treated with 10 M
U0126 or 0.1% dimethyl sulfoxide. Forty-
eight hours posttransfection, whole cell ex-
tracts were prepared. Immunoprecipitations
were performed on 500 g of precleared ex-
tract using anti-phospho-threonine antibod-
ies. The immunoprecipitated material was
electrophoresed and immublotted with anti-
Sp1 antibodies. Overexpression of Cx45 and
treatment with U0126 decreased phosphory-
lation of Sp1. (B) ROS17/2.8 cells were
treated as described above. Whole cell ex-
tracts were prepared, electrophoresed, and
immunoblotted using phospho-Sp1 (Thr739)
antibodies. The blot was then stripped and
reprobed using a total-Sp1 antibody. Overex-
pression of Cx45 or treatment with U0126
reduced the abundance of the phosphory-
lated Sp1. (C) Chromatin immunoprecipita-
tions were performed under these conditions
as described in Materials and Methods. The ability of Sp1 antibodies to immunoprecipitate the osteocalcin promoter (top) was markedly
reduced by treatment of the cells with 10 M U0126 or by overexpression of Cx45. Similar results were achieved with the collagen I 1 gene
promoter (bottom). The primers used for these studies span the CxREs in both of these promoters.
Figure 8. Model of gap junctional
modulation of gene transcription.
Gap junctional communication per-
mits the intercellular propagation
of second messengers that activate
the ERK/PI3K signal cascades.
These signals converge on nuclear
function by regulating the recruit-
ment of the transactivator Sp1 to
the CxRE in the promoter, leading
to robust transcription. When gap
junctional communication is dis-
rupted the cellular response is at-
tenuated, due to the failure to prop-
agate signals among cells. Putative
steps are highlighted by dotted lines.
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Interestingly, Ras and PI3K are recruited to the inner
leaflet of the plasma membrane. We hypothesize that Ras
and/or PI3K interact either directly or indirectly with con-
nexins, contributing to the assembly of a signaling complex
in association with the gap junction plaque. Such a spatial
arrangement would provide for efficient signaling as second
messengers are trafficked through the gap junctional chan-
nels. Indeed, numerous signal proteins have been demon-
strated in various cell types to interact with Cx43, including
c-src (Giepmans et al., 2001; Toyofuku et al., 2001), protein
kinase C (PKC)  and  (Doble et al., 2000; Bowling et al.,
2001; Schulz et al., 2003), and p38 MAPK (Schulz et al., 2003).
Furthermore, many of these interactions are connexin-iso-
type specific (Herve et al., 2004). Cx43 is also a target for ERK
MAPK, PKC, PI3K and src phosphorylation, indicating at
least a transient physical association (Lampe and Lau, 2000,
2004; Cruciani and Mikalsen, 2002). Additionally, signaling
via Cx43 hemichannels has been implicated in ERK activa-
tion in a noncanonical manner to provide antiapoptotic sig-
nals to osteoblasts (Plotkin et al., 2002).
The notion that gap junctions are required for optimal
responsiveness of bone cells to extracellular cues has been
demonstrated in various settings. Using an antisense RNA
approach to decrease Cx43 expression, gap junctional com-
munication has been shown to be required for a full osteo-
blastic response to parathyroid hormone (Van der Molen et
al., 1996). Similar results were obtained using chemical in-
hibitors of gap junctions (Schiller et al., 2001b). In chondro-
cytes, inhibitors of gap junctional communication were dem-
onstrated to block chondrogenic differentiation induced by
bone morphogenetic protein-2 (Zhang et al., 2002). It is note-
worthy that both of these extracellular ligands can activate
the ERK cascade in osteoblasts (Lou et al., 2000; Swarthout et
al., 2001; Lai and Cheng, 2002; Xiao et al., 2002). Furthermore,
ERK activity is important for osteogenesis (Lai et al., 2001)
and osteoblast-specific gene transcription (Xiao et al., 2002;
Zhao et al., 2002; Qiao et al., 2004). In fact, it is likely that the
delayed mineralization and cell autonomous osteoblast dys-
function observed in the genetically ablated Cx43 null mice
(Lecanda et al., 2000) is a result of decrease hormonal re-
sponsiveness, manifested at least in part as diminished ERK
activation.
In conclusion, we have demonstrated that when Cx43
function is attenuated either by Cx45 overexpression or
treatment with a gap junction inhibitor, the activity of ERK
is markedly decreased in response to extracellular cues (e.g.,
serum stimulation). The consequences of which is altered
transcription factor recruitment to CxREs and attenuated
gene transcription. These data demonstrate that Cx43-gap
junctions are important for the elaboration of an “optimal”
response of a population of cells. By understanding the
mechanisms of how gap junctions propagate signals, we
gain critical insight into the biologically relevant molecules
that pass through them.
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